medwireNews: Research presented at the ERS Congress 2024 supports sulthiame 200 or 300 mg as a drug therapy for obstructive sleep apnea (OSA), showing it consistently reduces sleep disordered breathing and improves sleep quality.
11-09-2024 | Obstructive Sleep Apnea | News